Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Cardiovascular diseases and diabetes

There is a need for action

    • Cardiology
    • Endocrinology and Diabetology
    • News
    • Partner Content
    • Prevention and health care
    • RX
  • 2 minute read

In patients with type 2 diabetes, the risk of heart attack or stroke is doubled, and the risk of arterial occlusive disease is even quintupled. With a focus on prevention, the “National Strategy on Cardiovascular Diseases, Stroke and Diabetes” defines the priority need for action for the next eight years.

The “National Strategy on Cardiovascular Diseases, Stroke and Diabetes” launched in November 2016 specifically addresses the phenomenon of multimorbidity in cardiovascular diseases and addresses the risk factors. Cardiovascular disease, stroke and diabetes are treated as a common action area. Special emphasis is placed on diabetes. Worldwide and also in Switzerland, there are signs of an increase – especially in older patients and in men.

Obesity and genetic factors

In the 75-plus age group, 18 percent of men and 9 percent of women have been diagnosed with diabetes at some point in their lives. The main cause of this increase is the spread of obesity in the population. However, genetic factors also play a role, which explains, among other things, why the disease is more common in certain population groups with a migration background.

As these diseases increase, so do the resource needs. The direct medical costs of all chronic diseases (NCDs) exceeded CHF 51 billion in 2011 and accounted for 80 percent of total healthcare costs. Cardiovascular diseases and diabetes are the top direct cost drivers with a total of CHF 11.3 billion per year.

Modifiable risk factors

According to recent estimates, modifiable risk factors are responsible for 60 to 80 percent of cardiovascular diseases, which can be favorably influenced by lifestyle adjustments or medical prevention. These risk factors are in particular: Obesity, excessive alcohol consumption, high blood sugar/diabetes, tobacco consumption, high blood pressure, lack of exercise, stress/psychosocial factors, unfavorable blood lipid levels/cholesterol, unbalanced diet. Overall, the strategy defines the priority need for action in three fields: 1. prevention and early detection, 2. to provide appropriate care for the patients and their environment, 3. data, quality and funding.

Expansion of case management

For diabetes patients, the additional priority need for action is to improve counseling and expand case management across the entire patient pathway. Another focus is on improving the prevention and early detection of diabetes-related diseases and complications.

The aim of diabetes prevention and early detection is to reduce the number of diabetes cases by promoting a healthy lifestyle and creating suitable conditions. Individuals at increased risk should be supported by professionals to optimize their lifestyle and thereby minimize or treat diabetes-related risk factors. The strategy also states that type 2 diabetes should be diagnosed at an earlier stage.

Source: CardioVasc Suisse (2016) “National Strategy Cardiovascular Diseases, Stroke and Diabetes 2017-2024”.

The strategy paper can be downloaded in German and French at www.cardiovascsuisse.ch/strategie.

 

CARDIOVASC 2017; 16(1): 26-27

Autoren
  • Karin Diodà
Publikation
  • CARDIOVASC
Related Topics
  • cardiovascular disease
  • Diabetes
Previous Article
  • Shop window disease

Trivialized, underestimated, inadequately treated and potentially fatal

  • Angiology
  • Education
  • RX
View Post
Next Article
  • Dermatophytoses

Update on clinic, epidemiology and diagnosis.

  • Dermatology and venereology
  • Education
  • Infectiology
  • RX
View Post
You May Also Like
View Post
  • 7 min
  • Geriatric patients

Micronutrient Intake in Older Adults

    • RX
    • Education
    • General Internal Medicine
    • Geriatrics
    • Nutrition
View Post
  • 7 min
  • Crohn's disease: focus on long-term results

“Top-down” approach or classic step therapy?

    • RX
    • Congress Reports
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Studies
View Post
  • 4 min
  • SwissDiab Study: New Analysis Published

How are diabetes complications associated with quality of life?

    • RX
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Studies
View Post
  • 6 min
  • Pre-acclimatization on Mount Everest

Exploring the physiological limits

    • RX
    • Congress Reports
    • General Internal Medicine
    • Pneumology
    • Studies
    • Tropical and travel medicine
View Post
  • 5 min
  • Viloxazine for ADHD

A non-stimulating option—but with limited evidence

    • RX
    • Education
    • Neurology
    • Pediatrics
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • Studies
View Post
  • 6 min
  • Preclinical study on phytotherapeutic agent

Active ingredient combination of peppermint and caraway oil modified fecal microbiota

    • RX
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Pharmaceutical medicine
    • Phytotherapy
    • Studies
View Post
  • 4 min
  • Casuistry

Rituximab used effectively against IgG4-RD colitis

    • RX
    • Cases
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Radiology
    • Rheumatology
View Post
  • 5 min
  • Sarcoidosis

New options from JAKi to mTOR

    • RX
    • Congress Reports
    • General Internal Medicine
    • Pneumology
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Current State of Knowledge and New Therapeutic Approaches
  • 2
    Why is it so hard to lose weight?
  • 3
    Functional limb preservation between infection control, vascular medicine and resurfacing
  • 4
    Algorithms, avatars and the unburdened mind
  • 5
    Communication as the key to therapy adherence

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.